0.9102
price up icon1.21%   0.0109
 
loading
Schlusskurs vom Vortag:
$0.8993
Offen:
$0.9062
24-Stunden-Volumen:
147.71K
Relative Volume:
1.28
Marktkapitalisierung:
$51.95M
Einnahmen:
$33.79M
Nettoeinkommen (Verlust:
$-18.67M
KGV:
-1.517
EPS:
-0.6
Netto-Cashflow:
$-19.17M
1W Leistung:
-0.62%
1M Leistung:
-12.48%
6M Leistung:
+1.13%
1J Leistung:
-26.00%
1-Tages-Spanne:
Value
$0.9062
$0.9501
1-Wochen-Bereich:
Value
$0.89
$0.97
52-Wochen-Spanne:
Value
$0.70
$2.15

Cytosorbents Corp Stock (CTSO) Company Profile

Name
Firmenname
Cytosorbents Corp
Name
Telefon
973-329-8885
Name
Adresse
305 COLLEGE ROAD EAST, PRINCETON, NJ
Name
Mitarbeiter
186
Name
Twitter
@CytoSorbents
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
CTSO's Discussions on Twitter

Vergleichen Sie CTSO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
CTSO
Cytosorbents Corp
0.9102 51.95M 33.79M -18.67M -19.17M -0.60
Medical Devices icon
ABT
Abbott Laboratories
118.95 208.18B 41.22B 5.77B 6.49B 2.94
Medical Devices icon
SYK
Stryker Corp
388.14 148.70B 21.97B 3.59B 3.21B 6.74
Medical Devices icon
BSX
Boston Scientific Corp
90.75 133.32B 15.91B 1.79B 1.89B 0.82
Medical Devices icon
MDT
Medtronic Plc
86.27 111.27B 33.00B 4.29B 5.50B 2.71
Medical Devices icon
EW
Edwards Lifesciences Corp
72.07 42.66B 6.60B 4.16B 490.10M 2.34

Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-09-07 Eingeleitet B. Riley Securities Buy
2021-10-14 Fortgesetzt B. Riley Securities Buy
2020-09-17 Eingeleitet Jefferies Buy
2020-09-01 Eingeleitet SVB Leerink Outperform
2017-08-08 Bestätigt Maxim Group Buy
2016-10-26 Eingeleitet Aegis Capital Buy
2016-05-24 Eingeleitet Maxim Group Buy
2015-10-29 Hochstufung WBB Securities Speculative Buy → Buy
2015-05-12 Bestätigt MLV & Co Buy
2015-04-01 Bestätigt MLV & Co Buy
2015-03-05 Eingeleitet MLV & Co Buy
2015-02-25 Eingeleitet WBB Securities Speculative Buy
2015-01-27 Bestätigt H.C. Wainwright Buy
Alle ansehen

Cytosorbents Corp Aktie (CTSO) Neueste Nachrichten

pulisher
Nov 26, 2024

CytoSorbents to Present at Piper Sandler's 36th Annual Healthcare Conference | CTSO Stock News - StockTitan

Nov 26, 2024
pulisher
Nov 26, 2024

Cytosorbents (NASDAQ:CTSO) Now Covered by StockNews.com - MarketBeat

Nov 26, 2024
pulisher
Nov 20, 2024

Cytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.com - Defense World

Nov 20, 2024
pulisher
Nov 15, 2024

Granahan Investment Management Reduces Stake in CytoSorbents Cor - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

FY2024 EPS Estimates for Cytosorbents Decreased by Analyst - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

FY2024 EPS Estimate for Cytosorbents Decreased by Analyst - MarketBeat

Nov 14, 2024
pulisher
Nov 11, 2024

Cytosorbents Corporation (NASDAQ:CTSO) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 11, 2024
pulisher
Nov 11, 2024

CytoSorbents And Converge Biotech Announce Strategic - GlobeNewswire

Nov 11, 2024
pulisher
Nov 11, 2024

CytoSorbents Expands Into India Through Strategic Converge Biotech Partnership | CTSO Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 10, 2024

StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO) - MarketBeat

Nov 10, 2024
pulisher
Nov 08, 2024

CytoSorbents Corp (CTSO) Q3 2024 Earnings Call Highlights: Stron - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

CytoSorbents Corp (CTSO) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Improved ... - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

Cytosorbents Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 08, 2024
pulisher
Nov 08, 2024

CytoSorbents Corporation’s Q3 2024 Financial Highlights - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

CytoSorbents: Q3 Earnings Snapshot - CT Insider

Nov 07, 2024
pulisher
Nov 07, 2024

CytoSorbents Reports Third Quarter 2024 Financial and Operational Results - StockTitan

Nov 07, 2024
pulisher
Nov 06, 2024

CytoSorbents Corp (CTSO) Q3 2024: Everything You Need to Know Ah - GuruFocus.com

Nov 06, 2024
pulisher
Nov 06, 2024

CytoSorbents Corp (CTSO) Q3 2024: Everything You Need to Know Ahead of Earnings - Yahoo Finance

Nov 06, 2024
pulisher
Nov 05, 2024

CytoSorbents (STU:HQE1) 3-Year EPS without NRI Growth Rate : -38.10% (As of Jun. 2024) - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

CytoSorbents (STU:HQE1) 3-Year EBITDA Growth Rate : -37.70% (As of Jun. 2024) - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

CytoSorbents (STU:HQE1) 3-Year FCF Growth Rate : -39.10% (As of Jun. 2024) - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

CytoSorbents (STU:HQE1) 5-Day RSI : 14.64 (As of Nov. 05, 2024) - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

CytoSorbents (STU:HQE1) Operating Income : €-23.16 Mil (TTM As of Jun. 2024) - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification - StockTitan

Nov 04, 2024
pulisher
Nov 02, 2024

Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com - MarketBeat

Nov 02, 2024
pulisher
Oct 31, 2024

Cytosorbents (CTSO) to Release Earnings on Thursday - MarketBeat

Oct 31, 2024
pulisher
Oct 29, 2024

Cytosorbents (NASDAQ:CTSO) and Caliber Imaging & Diagnostics (OTCMKTS:LCDX) Critical Comparison - Defense World

Oct 29, 2024
pulisher
Oct 22, 2024

Analyst Scoreboard: 5 Ratings For CytoSorbents - Benzinga

Oct 22, 2024
pulisher
Oct 22, 2024

Expert Outlook: CytoSorbents Through The Eyes Of 5 Analysts - Benzinga

Oct 22, 2024
pulisher
Oct 22, 2024

FDA begins review of CytoSorbents' bleeding reduction device - Investing.com

Oct 22, 2024
pulisher
Oct 22, 2024

FDA begins review of CytoSorbents' bleeding reduction device By Investing.com - Investing.com UK

Oct 22, 2024
pulisher
Oct 22, 2024

FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review - StockTitan

Oct 22, 2024
pulisher
Oct 22, 2024

CytoSorbents (STU:HQE1) Forward Dividend Yield % : 0.00% (As of Nov. 05, 2024) - GuruFocus.com

Oct 22, 2024
pulisher
Oct 17, 2024

CytoSorbents to Report Third Quarter 2024 Operating and Financial Results - StockTitan

Oct 17, 2024
pulisher
Oct 17, 2024

Cytosorbents (NASDAQ:CTSO) Now Covered by Analysts at StockNews.com - MarketBeat

Oct 17, 2024
pulisher
Oct 16, 2024

Cytosorbents Co. (NASDAQ:CTSO) Short Interest Down 5.7% in September - MarketBeat

Oct 16, 2024
pulisher
Oct 09, 2024

CytoSorbents Corp (CTSO) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance

Oct 09, 2024
pulisher
Oct 02, 2024

CytoSorbents maintains Buy rating from B.Riley with no change in target price - Investing.com

Oct 02, 2024
pulisher
Oct 01, 2024

Cytosorbents announces $20 million "at the market" equity offering - Investing.com

Oct 01, 2024
pulisher
Oct 01, 2024

Cytosorbents Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits - Quantisnow

Oct 01, 2024
pulisher
Oct 01, 2024

DrugSorb-ATR seeks FDA priority review for surgery bleeding - Investing.com

Oct 01, 2024
pulisher
Oct 01, 2024

CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update - The Manila Times

Oct 01, 2024
pulisher
Oct 01, 2024

Cytosorbents (NASDAQ:CTSO) Research Coverage Started at StockNews.com - MarketBeat

Oct 01, 2024
pulisher
Sep 30, 2024

Cytosorbents (NASDAQ:CTSO) shareholders have endured a 81% loss from investing in the stock three years ago - Yahoo Finance

Sep 30, 2024
pulisher
Sep 23, 2024

Cytosorbents (NASDAQ:CTSO) Earns Hold Rating from Analysts at StockNews.com - MarketBeat

Sep 23, 2024

Finanzdaten der Cytosorbents Corp-Aktie (CTSO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices STE
$217.47
price up icon 0.65%
medical_devices ZBH
$112.02
price up icon 1.25%
medical_devices PHG
$27.15
price up icon 0.89%
$78.10
price up icon 0.21%
$83.00
price up icon 0.59%
medical_devices EW
$72.07
price up icon 0.73%
Kapitalisierung:     |  Volumen (24h):